COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 1349: Articles 13481-13490  | Next

Endothelial dysfunction determines severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
Ruhl, L., Pink, I., Kuehne, J. F., Beushausen, K., Keil, J., Christoph, S., Sauer, A., Boblitz, L., Schmidt, J., David, S., Jaeck, H.-M., Roth, E., Cornberg, M., Schulz, T. F., Welte, T., Hoeper, M., Falk, C. S.
10.1101/2021.07.08.21260169 — Posted: 2021-07-10
COVID-19 and Black Fungus: Analysis of the Public Perception through Machine Learning
Islam, M. N., Khan, N. I., Mahmud, T.
10.1101/2021.07.08.21260188 — Posted: 2021-07-10
Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19
Gaitan-Duarte, H. G., alvarez-Moreno, C., Rincon-Rodriguez, C. J., Yomayusa-Gonzalez, N., Cortes, J. A., Villar, J. C., Bravo-Ojeda, J. S. S., Garcia-Pena., A., Adarme-Jaimes., W., Rodriguez-Romero, V. A., Villate-Soto, S. L., Buitrago, G., Chacon-Sarmiento, J., Macias-Quintero, M., Vaca, C. P., Gomez-Restrepo, C., Rodriguez-Malagon., N.
10.1101/2021.07.06.21260085 — Posted: 2021-07-10
Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial.
Cadegiani, F. A., Zimerman, R. A., Fonseca, D. N., Correia, M. N., McCoy, J., Wambier, C. G., Goren, A.
10.1101/2021.07.06.21260086 — Posted: 2021-07-10
Decoding Clinical Biomarker Space of COVID-19: Exploring Matrix Factorization-based Feature Selection Methods
Saberi-Movahed, F., Mohammadifard, M., Mehrpooya, A., Rezaei-Ravari, M., Berahmand, K., Rostami, M., Karami, S., Najafzadeh, M., Hajinezhad, D., Jamshidi, M., Abedi, F., Mohammadifard, M., Farbod, E., Safavi, F., Dorvash, M., Eftekhari, M., Vahedi, S., Saberi-Movahed, F., Tavassoly, I.
10.1101/2021.07.07.21259699 — Posted: 2021-07-09
Three-step rhythmic breathing exercise and COVID-19: A cross-sectional study
Pandya, A., Mavalankar, D., Majithia, P.
10.1101/2021.07.07.21259527 — Posted: 2021-07-09
Myeloid-derived suppressor cells in the blood of Iranian COVID-19 patients
Mortaz, E., movassaghi, m., Bassir, A., Dezfuli, N. K., Roofchayee, N. D., Jamaati, H., Garssen, J., Adcock, I. M. A. M.
10.1101/2021.07.07.21260141 — Posted: 2021-07-09
COVID-19 Serology Control Panel Using the Dried Tube Specimen Method
Windsor, W. J., Knight, V., Merkel, P. A., Lamb, M. M., Santiago, M. L., McCarthy, M. K., Morrison, T. E., Kedl, R. M., Frazer-Abel, A., Guo, K., Andersen, G., Huey, L., Barrett, B. S., Colon-Franco, J. M., Chu, M. C.
10.1101/2021.07.07.21260101 — Posted: 2021-07-09
Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing
Rios, G., Lacoux, C., Leclercq, V., Diamant, A., Lebrigand, K., Lazuka, A., Soyeux, E., Lacroix, S., Fassy, J., Couesnon, A., Thiery, R., Mari, B., Pradier, C., Waldmann, R., Barbry, P.
10.1101/2021.07.09.21257475 — Posted: 2021-07-09
RISK OF ON JOB NON COMPLIANCE TOWARDS VARIOUS COVID-19 STANDARD & TRANSMISSION BASED INFECTION PREVENTION & CONTROL MEASURES/PRECAUTIONS AMONG THE HEALTHCARE WORKS WORKING IN OPD SETTINGs OF PUBLIC SECTOR TERTIORY CARE HOSPITALS OF QUETTA BALOCHISTAN. (Prospective cohort study).
Arif, M., Abdullah, M., Chaudhry, A., Hussain, Z., Larik, E.
10.1101/2021.07.08.21260212 — Posted: 2021-07-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).